# DENTSPLY SIRONA Inc. (XRAY) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $11.38, market value $2.3 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). DENTSPLY SIRONA Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.23**. A PEG of 0.23 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.6×**. Each dollar of revenue is priced at 0.6×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.7×**. The shares trade at 1.7× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 109.5×**. Enterprise value is 109.5× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 6.3%** (5-yr avg 5.2%). Free cash flow equals 6.3% of the market value, above its five-year average of 5.2%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.

## Profitability
- **Gross margin: 49.5%**. DENTSPLY SIRONA Inc. keeps 49.5% of revenue after the direct cost of what it sells.
- **Operating margin: -8.5%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -16.3%**. The company reported a net loss over the last twelve months.
- **Return on equity: -44.7%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -7.3%**. Return on all capital, debt included, is -7.3%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -10.1%**. Each dollar of assets produces -10.1% of profit.

## Growth
- **Revenue growth (1 yr): -3.0%** (3-yr -2.1%/yr, 5-yr 2.0%/yr). Revenue fell 3.0% over the last year, against 2.0% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 33.0%**. Earnings per share rose 33.0%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -34.4%/yr**. Free cash flow has compounded at -34.4% a year over three years.

## Financial health
- **Debt to equity: 1.74**. Debt is 1.74 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Altman Z-score: 1.10**. A Z-score of 1.10 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 2.80%** ($0.32 per share, trailing). DENTSPLY SIRONA Inc. yields 2.80%, a modest yield more typical of a growth-oriented payer.
- **Consecutive years of increases: 26**. 26 straight years of increases (the data covers 26 years, so this may be longer): a record very few companies hold.
- **Dividend growth (5 yr): 9.9%/yr** (1-yr 0.0%). The dividend has grown 9.9% a year over five years.

## Price and momentum
- **Total return (1 yr): -18.4%** (YTD -0.4%, 3-mo 13.8%). The shares are down 18.4% over twelve months including dividends.
- **From 52-week high: -22.9%** (20.9% above the low). Trading 23% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 47**. An RSI of 47 is neutral.
- **Beta (1 yr): 1.35** (volatility 46%). Beta of 1.35 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=XRAY · Page: https://foliofundamentals.com/stocks/xray

Not investment advice.